Unidirectional inversion of ibuprofen in Caco-2 cells: developing a suitable model for presystemic chiral inversion study.
Intestinal chiral inversion of ibuprofen is still lacking direct evidence. In a preliminary experiment, ibuprofen was found to undergo inversion in Caco-2 cells. This investigation was thus conducted to determine the characteristics and influence of some biochemical factors on the chiral inversion of ibuprofen in Caco-2 cells. The effects of substrate concentration (2.5-40 microg/ml), cell density (0.5-2 x 10(6) cells/well), content of serum (0-20%), coexistence of S ibuprofen (corresponding doses), sodium azide (10 mM), exogenous Coenzyme A (CoA) (0.1-0.4 mM), and palmitic acid (5-25 microM) on inversion were examined. A stereoselective HPLC method based on the Chromasil-CHI-TBB column was developed for quantitative analysis of the drug in cell culture medium. The inversion ratio (F(i)) and elimination rate constant were calculated as the indexes of inversion extent. Inversion of ibuprofen in Caco-2 cells was found to be both dose and cell density dependent, indicating saturable characteristics. Addition of serum significantly inhibited the inversion, to an extent of 2.7 fold decrease at 20% content. Preexistence of S enantiomer exerted a significant inhibitory effect (p<0.01 for all tests). Sodium azide decreased the inversion ratio from 0.43 to 0.32 (p<0.01). Exogenous CoA and palmitic acid significantly promoted the inversion at all tested doses (p<0.01 for all tests). This research provided strong evidence to the capacity and capability of intestinal chiral inversion. Although long incubation times up to 120 h were required, Caco-2 cells should be a suitable model for chiral inversion research of 2-APAs considering the human-resourced and well-defined characteristics from the present study.
Hao
Haiping
H
Key Lab of Drug Metabolism & Pharmacokinetics, China Pharmaceutical University, Nanjing. hhp_770505@yahoo.com.cn
Wang
Guangji
G
Sun
Jianguo
J
Ding
Zuoqi
Z
Wu
Xiaolan
X
Roberts
Michael
M
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism*; D018938:Caco-2 Cells; D018929:Cell Culture Techniques; D003065:Coenzyme A; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007052:Ibuprofen / Q000378:metabolism*; D007413:Intestinal Mucosa / Q000378:metabolism*; D019308:Palmitic Acid; D019810:Sodium Azide; D013237:Stereoisomerism
D000894:Anti-Inflammatory Agents, Non-Steroidal; D019308:Palmitic Acid; D019810:Sodium Azide; D003065:Coenzyme A; D007052:Ibuprofen